BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abdelwahab KS, Ahmed Said ZN. Status of hepatitis C virus vaccination: Recent update. World J Gastroenterol 2016; 22(2): 862-873 [PMID: 26811632 DOI: 10.3748/wjg.v22.i2.862]
URL: https://www.wjgnet.com/1007-9327/full/v22/i2/862.htm
Number Citing Articles
1
Reham M. Dawood, Ghada M. Salum, Tawfeek H. Abdelhafez, Reem El Shenawy, Noha E. Ibrahim, Mostafa K. El Awady. Safety and tolerability of mice to repeated subcutaneous injections of a peptide mix as a potential vaccine against HCV infectionHuman Antibodies 2019; 27(2): 105 doi: 10.3233/HAB-180354
2
Narotam Narotam. Characterization of Hepatitis C Virus (HCV) Genotypes with Spectrum of its Viral LoadJournal of Analytical & Pharmaceutical Research 2016; 3(3) doi: 10.15406/japlr.2016.03.00058
3
Jinyu Han, Dandan Zhao, Dan Li, Xiaohua Wang, Zheng Jin, Kai Zhao. Polymer-Based Nanomaterials and Applications for Vaccines and DrugsPolymers 2018; 10(1): 31 doi: 10.3390/polym10010031
4
Sooram Banesh, Surajbhan Sevda. Bioreactor Design Concepts for Viral Vaccine Production2024; : 297 doi: 10.1016/B978-0-443-15378-5.00016-4
5
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospectsEuropean Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
6
Zahra Hasanshahi, Ava Hashempour, Farzane Ghasabi, Javad Moayedi, Zahra Musavi, Behzad Dehghani, Heidar Sharafi, Hassan Joulaei. First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patientsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01988-y
7
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
8
Md Abdul Kuddus, Sazia Khatun Tithi, Anip Kumar Paul, Moumita Mustareen, Azizur Rahman. Economic evaluation of a two-strain Hepatitis C vaccination model in Bangladesh using optimal control techniqueThe European Physical Journal Plus 2024; 139(8) doi: 10.1140/epjp/s13360-024-05502-7
9
Mona Razin, Abdel-Rahman B. Abdel-Ghaffar, Germine M. Hamdy, Dina N. Abd-Elshafy, Solaf Kamel, Mahmoud Mohamed Bahgat, Amany Sayed Maghraby. TLR3\TLR7 as Differentially Expressed Markers Among Viral, Nonviral, and Autoimmune Diseases in Egyptian PatientsViral Immunology 2021; 34(9): 607 doi: 10.1089/vim.2021.0006
10
Kimia Kardani, Azam Bolhassani, Mona Kardani, Elnaz Agi. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver DisordersJournal of Medical Microbiology and Infectious Diseases 2021; 9(3): 122 doi: 10.52547/JoMMID.9.3.122
11
Seroprevalence of Hepatitis B and C Infections Among HIV/AIDS Patients Attending Aminu Kano Teaching Hospital, Kano State, NigeriaUMYU Journal of Microbiology Research (UJMR) 2017; 2(1): 200 doi: 10.47430/ujmr.1721.029
12
Kimia Kardani, Parya Basimi, Mehrshad Fekri, Azam Bolhassani. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine developmentExpert Review of Clinical Pharmacology 2020; 13(9): 1001 doi: 10.1080/17512433.2020.1814743
13
Shahram Jalilian, Seyed Mahmoud Latifi, Manoochehr Makvandi, Ali Teimoori, Azarakhsh Azaran, Mehdi Parsanahad, Gholamabas Kayedani. The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a InfectionIndian Journal of Medical Microbiology 2017; 35(2): 262 doi: 10.4103/ijmm.IJMM_16_309
14
Vuyolwethu Khwaza, Buhle Buyana, Xhamla Nqoro, Ruwizhi Ngonidzashe, Opeoluwa O. Oyedeji, Blessing A. Aderibigbe. Polymeric Biomaterials for Healthcare Applications2022; : 41 doi: 10.1016/B978-0-323-85233-3.00002-1
15
María Q. Marín, Patricia Pérez, Carmen E. Gómez, Carlos Óscar S. Sorzano, Mariano Esteban, Juan García-Arriaza. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene ExpressionViruses 2018; 10(8): 414 doi: 10.3390/v10080414
16
Mahdi Mahjoub, Smohammad Mahboubi-Rabbani, Rouhollah Vahabpour, Afshin Zarghi, Elham Rezaee, Sayyed Abbas Tabatabai. Discovery of novel HCV inhibitors: design, synthesis and biological activity of phthalamide derivativesMedicinal Chemistry Research 2022; 31(11): 1916 doi: 10.1007/s00044-022-02947-2
17
Jin-Ching Lee, Chun-Kuang Lin, Chin-Kai Tseng, Yeh-Long Chen, Cherng-Chyi Tzeng, Chih-Hua Tseng. Discovery of 3-Amino-2-Hydroxypropoxyisoflavone Derivatives as Potential Anti-HCV AgentsMolecules 2018; 23(11): 2863 doi: 10.3390/molecules23112863
18
Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challengesWorld Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239
19
Noura H Abd Ellah, Hesham M Tawfeek, James John, Helal F Hetta. Nanomedicine as a Future Therapeutic Approach for Hepatitis C VirusNanomedicine 2019; 14(11): 1471 doi: 10.2217/nnm-2018-0348